- $128.11m
- $160.05m
- $37.60m
- 83
- 77
- 84
- 95
C2019 September 30th | C2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41 | 24.1 | 38.2 | 70.3 | 37.6 |
Cost of Revenue | |||||
Gross Profit | 32.7 | 18.2 | 32 | 63 | 34.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 118 | 59.9 | 28.2 | 32 | 27.7 |
Operating Profit | -77 | -35.9 | 9.97 | 38.4 | 9.87 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -54.2 | -32.2 | -6.87 | 24.6 | 18.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -40.7 | -24 | -6.22 | 20.4 | 13.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -40.7 | -24 | -6.22 | 20.4 | 13.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -40.7 | -24 | -6.22 | 20.4 | 13.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.176 | -0.418 | -0.241 | 0.489 | 0.299 |
Dividends per Share |